Mineralized Tissue: Histology, Biology and Biochemistry - Osteogenesis Imperfecta - page 37

[84] Salasznyk RM, Williams WA, Boskey A, Batorsky A, Plopper

GE. Adhesion to vitronectin and collagen I promotes osteogenic
differentiation of human mesenchymal stem cells. J Biomed
Biotechnol 2004;2004:24-34.

[92] Martínez-Glez V, Valencia M, Caparrós-Martín JA, et al.

Identiication of a mutation causing deicient BMP1 / mTLD pro-
teolytic activity in autosomal recessive osteogenesis imperfecta.
Hum Muta 2012;33:343-50.

[85] Alford AI, Terkhorn SP, Reddy AB, Hankenson KD.

Thrombospondin-2

[93] Marini JC, Cabral WA, Barnes AM, Chang W. Components of

the collagen prolyl3-hydroxylation complex are crucial for nor-
mal bone development. Cell Cycle 2007;64:1675-81.

regulates matrix mineralization in

MC3T3-E1 pre-osteoblasts. Bone 2010;46:464-71.

[86] Uno A, Miwa Y, Miyoshi K, et al. Constitutive expression of

thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits min-
eralization. J Cell Physiol 2006;209:322-32.

[94] Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives

on osteogenesis imperfecta. Nat Rev Endocrinol 2011;7:540-57.

[95] Sarathchandra P, Cassella JP, Ali SY. Enzyme histochemical

localisation of alkaline phosphatase activity in osteogenesis
imperfecta bone and growth plate: a preliminary study. Micron
2005;36:715-20.

[87] Marini JC, Forlino A, Cabral WA, et al. Consortium for osteogen-

esis imperfecta mutations in the helical domain of type I collagen:
regions rich in lethal mutations align with collagen binding sites
for integrins and proteoglycans. Hum Mutat 2007;28:209-21. [96] Aubin I, Adams CP, Opsahl S, et al. A deletion in the gene encod-

ing sphingomyelin phosphodiesterase 3 (Smpd3) results in osteo-
genesis and dentinogenesis imperfecta in the mouse. Nat Genet
2005;37:803-5.

[88] Uveges TE, Collin-Osdoby P, Cabral WA, et al. Cellular mecha-

nism of decreased bone in Brtl mouse model of OI: imbalance
of decreased osteoblast function and increased osteoclasts and
their precursors. J Bone Miner Res 2008;23:1983-94. [97] Khavandgar Z, Poirier C, Clarke CJ, et al. A cell-autonomous

requirement for neutral sphingomyelinase 2 in bone mineraliza-
tion. J Cell Biol 2011;194:277-89.

[89] Cabral WA, Fratzl-Zelman N, Roschger P, Marini JC. Cellular

dysregulation of gene expression in response to abnormal extra-
cellular matrix may contribute to matrix hypermineralization
in osteogenesis imperfecta. European Calciied Tissues Society
2011 ECTS / IBMS11-ABS-1597.

[98] Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH,

Klaushofer K, Rauch F. Evidence that abnormal high bone min-
eralization in growing children with osteogenesis imperfecta is
not associated with speciic collagen mutations. Calcif Tissue Int
2008;82:263-70.

[90] Forlino A, Tani C, Rossi A, et al. Differential expression of both

extracellular and intracellular proteins is involved in the lethal
or nonlethal phenotypic variation of BrtlIV, a murine model for
osteogenesis imperfecta. Proteomics 2007;7:1877-91.

[99] Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen

KJ, Müller R. Guidelines for assessment of bone microstructure
in rodents using micro-computed tomography. J Bone Miner Res
2010;25:1468-86.

[91] Posey KL, Hankenson K, Veerisetty AC, Bornstein P, Lawler J,

Hecht JT. Skeletal abnormalities in mice lacking extracellular
matrix proteins, thrombospondin-1, thrombospondin-3, thrombo-
spondin-5, and type IX collagen. Am J Pathol 2008;172:1664-74.